Ppar-gamma agonists for the induction of cationic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/136 (2006.01) A61K 31/166 (2006.01) A61K 31/196 (2006.01) A61K 31/343 (2006.01) A61K 31/357 (2006.01) A61K 31/4439 (2006.01) A61K 31/47 (2006.01) A61K 31/606 (2006.01) A61K 31/609 (2006.01) A61P 1/00 (2006.01) A61P 1/02 (2006.01) A61P 1/04 (2006.01) A61P 11/02 (2006.01) A61P 17/00 (2006.01) G01N 33/94 (2006.01)

Patent

CA 2678159

Rosiglitazone, 5-ASA or structurally analogous Compounds according to the general formula (I): or Compounds according to the general formula (Ia): For the induction of CAMP expression in tissues having PPAR-gamma receptors. Such tissues include epithelia or mucosae tissue having PPAR-gamma receptors and of particular interest .iota.s CAMP expression in the gut

L'invention concerne la rosiglitazone, le 5-ASA, des composés structurellement analogues de formule (I), ou des composés de formule (Ia), destinés à induire l'expression de CAMP dans des tissus présentant des récepteurs de PPAR-gamma. De tels tissus comprennent des tissus épithéliaux ou mucosaux présentant des récepteurs de PPAR-gamma. L'invention concerne en particulier l'expression de CAMP dans l'intestin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ppar-gamma agonists for the induction of cationic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ppar-gamma agonists for the induction of cationic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ppar-gamma agonists for the induction of cationic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1992209

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.